Financhill
Sell
21

BIOLQ Quote, Financials, Valuation and Earnings

Last price:
$0.0100
Seasonality move :
8.99%
Day range:
$0.0080 - $0.0082
52-week range:
$0.0040 - $0.2000
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
--
Volume:
4.8K
Avg. volume:
63.1K
1-year change:
-95.36%
Market cap:
$384.3K
Revenue:
$49.2M
EPS (TTM):
-$2.04

Earnings Data

Next earnings date for BIOLQ
May 12
2025
Most recent earnings per share
-$0.04
Missed by $0.04
(Nov 7/2024)
Consensus Estimate
--
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BIOLQ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/28/2025 Q4 -- -- -- -- --
11/07/2024 Q3 -- $10.9M -$0.04 -- --
08/08/2024 Q2 $13.5M $11.6M -$0.08 -$0.01 -$0.07
03/31/2024 Q1 $10M $10.1M -$0.36 -$0.15 -$0.21
12/31/2023 Q4 $13.2M $13.5M -$1.56 -$0.90 -$0.66
09/30/2023 Q3 -- -- -$3.89 -$1.45 -$2.44
06/30/2023 Q2 -- -- -$26.14 -$6.00 -$20.14
03/31/2023 Q1 -- -- -$17.83 -$10.00 -$7.83
12/31/2022 Q4 -- -- -$128.00 -$16.00 -$112.00
09/30/2022 Q3 -- -- -$110.36 -$42.00 -$68.36
06/30/2022 Q2 -- -- -$91.98 -$58.50 -$33.48
03/31/2022 Q1 -- -- -$81.00 -- --
12/31/2021 Q4 -- -- -$75.00 -- --
09/30/2021 Q3 -- -- -$54.00 -- --
06/30/2021 Q2 -- -- -$12.00 -- --
03/31/2021 Q1 -- -- -$138.00 -- --
12/31/2020 Q4 -- -- -$175.00 -- --
09/30/2020 Q3 -- -- -$525.00 -- --
06/30/2020 Q2 -- -- -$300.00 -- --
03/31/2020 Q1 -- -- -$475.00 -- --
12/31/2019 Q4 -- -- -$325.00 -- --
09/30/2019 Q3 -- -- -$625.00 -- --
06/30/2019 Q2 -- -- -$450.00 -- --
03/31/2019 Q1 -- -- -$575.00 -- --
12/31/2018 Q4 -- -- -$825.00 -- --
09/30/2018 Q3 -- -- -$575.00 -- --
06/30/2018 Q2 -- -- -$600.00 -- --
03/31/2018 Q1 -- -- -$625.00 -- --
12/31/2017 Q4 -- -- -$525.00 -- --
09/30/2017 Q3 -- -- -$750.00 -- --
06/30/2017 Q2 -- -- -$1,525.00 -- --
03/31/2017 Q1 -- -- -$750.00 -- --
12/31/2016 Q4 -- -- -$821.36 -- --
09/30/2016 Q3 -- -- -$1,056.03 -- --
06/30/2016 Q2 -- -- -$704.02 -- --
03/31/2016 Q1 -- -- -$821.36 -- --
12/31/2015 Q4 -- -- -$469.35 -- --
09/30/2015 Q3 -- -- -$1,056.03 -- --
06/30/2015 Q2 -- -- -$1,408.05 -- --

Biolase Earnings Questions

  • How Much did Biolase Generate in Revenue Last Quarter?

    Biolase reported $10.9M worth of top line sales in its most recent quarter.

  • Did Biolase Beat Earnings Last Quarter?

    Biolase announced earnings per share of -$0.04 which represents a miss of analyst forecast a -- per share.

  • Is Biolase Profitable?

    Biolase reported $4.4M that represents $0.12 per share over the last quarter.

  • What is the Analyst Consensus for Biolase EPS Next Year?

    Biolase's earnings are forecast to decrease from -$29.44 per share to -$9.63 per share next year representing a decrease of -99.22%.

  • When is Biolase's Earnings Date?

    Biolase's next earnings date is May 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock